FRAMEWORK FOR IMPLEMENTING THE GLOBAL STRATEGY TO ELIMINATE YELLOW FEVER EPIDEMICS (EYE), IN THE AFRICAN REGION. Report of the Secretariat
|
|
- Darren Edwards
- 6 years ago
- Views:
Transcription
1 13 June 2017 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixty-seventh session Victoria Falls, Republic of Zimbabwe, 28 August 1 September Provisional agenda item 11 FRAMEWORK FOR IMPLEMENTING THE GLOBAL STRATEGY TO ELIMINATE YELLOW FEVER EPIDEMICS (EYE), IN THE AFRICAN REGION Report of the Secretariat EXECUTIVE SUMMARY 1. Despite the availability of a vaccine with life-long immunity, the majority of countries in the World Health Organization African Region are at risk of yellow fever (YF). This is because the national immunization coverage for YF is not yet optimal. 2. To respond to frequent YF outbreaks in West Africa, the YF Initiative (YFI) has, since 2005, supported efforts to reduce the burden of this disease. Although surveillance and response capacities have been progressively improved, over 440 million people remain at risk of YF in the African Region. The recent yellow fever outbreak in Angola and DRC clearly demonstrated that this disease is still a serious health risk within and outside the Region. 3. Currently, the Region is challenged by suboptimal routine YF vaccination, frequent vaccine stock-outs and inadequate implementation of the International Health Regulations (IHR 2005). Further, other risk factors such as climate change and rapid urbanization lead to frequent YF outbreaks. 4. In view of the foregoing, a global strategy to eliminate yellow fever epidemics (EYE) for the period was developed in This regional implementation framework has been developed to support the rollout of the global strategy. The three strategic objectives are: (i) to protect populations in all 35 countries at risk through preventive and routine vaccination; (ii) to prevent the international spread of YF through vaccination of travellers and robust screening at major points of entry; and (iii) to detect, confirm and rapidly contain YF outbreaks. 5. The framework also clearly stipulates the targets and milestones. With a single dose of YF vaccine per person, elimination of YF epidemics is indeed a quick public health gain. The Regional Committee is invited to examine and adopt the actions proposed in this framework.
2 CONTENTS Paragraphs INTRODUCTION CURRENT SITUATION ISSUES AND CHALLENGES THE REGIONAL IMPLEMENTATION FRAMEWORK PRIORITY INTERVENTIONS AND ACTIONS ANNEXES 1. Priority interventions to eliminate YF epidemics in the African Region Proposed sequencing of preventive mass vaccination campaigns over time, Africa (Number of doses (1000s) Global YF vaccine supply outlook Key Regional indicators Page
3 ABBREVIATIONS AEFI CDC EPI EQA FNV ICG IHR IPD MCV1 PMVC QC UNICEF WHO WUENIC YF YFI Adverse Events Following Immunization United States Centers for Disease Control and Prevention Expanded Programme on Immunization External Quality Assessment French Neurotropic Vaccine International Coordinating Group on Vaccine Provision International Health Regulations Institut Pasteur, Dakar Measles Containing Vaccine (first dose) Preventive Mass Vaccination Campaign Quality Control United Nations Children's Fund World Health Organization WHO UNICEF Estimates of National Immunization Coverage Yellow Fever YF Initiative
4 Page 1 INTRODUCTION 1. Yellow fever (YF) remains a challenge for public health in Africa, despite the availability of a vaccine with life-long immunity. 1 Although mass immunization campaigns have greatly reduced its incidence, outbreaks continue to occur through a sylvatic cycle involving monkeys as a natural reservoir. More countries are at risk of the resurgence of the Aedes aegypti mosquito, the primary vector responsible for YF. 2. In 2005, frequent outbreaks in West Africa led to the launch of the YF Initiative (YFI), with support from Gavi, the Vaccine Alliance, resulting in the protection of most people in this subregion. 2 The YFI enabled vaccination of 114 million people and has, since 2010, eliminated YF epidemics in urban areas in West Africa The 2016 unprecedented YF outbreak in Angola that spread to the Democratic Republic of the Congo prompted WHO to develop a global strategy to eliminate YF epidemics (EYE) by The EYE strategy promotes vaccination and calls for building resilient urban centres and strengthening the application of the International Health Regulations (IHR 2005) This implementation framework has been formulated to guide Member States to roll out the EYE strategy in the African Region. It describes priority interventions and actions for WHO and partners, and Member States that are at risk of YF epidemics (see Annex 1). CURRENT SITUATION 5. In the African Region, 23 6 of the 33 7 countries at risk have introduced the YF vaccine in their routine immunization programmes. However, only Gambia, Guinea-Bissau and Sao Tome and Principe attained 90% population coverage in The YF national immunization coverage varies from 20% to 97% with a median coverage of 80%, following preventive mass vaccination campaigns (PMVC). Between 2007 and 2015, combined PMVCs and routine immunization reduced the burden of YF by more than half, averted more than half a million cases and protected more than 150 million people. 3 The population immunity calculated from PMVCs, routine immunization, outbreak response and catch-up campaigns varies from 0% to 90% (median value of 50%). 6. Through the YFI, Member States capacities for early detection and prompt response to outbreaks have been strengthened. 2 Case-based YF surveillance has been established in 16 countries, 8 and the capacity of national laboratories for serological screening and laboratory confirmation has been strengthened through training by the WHO regional reference laboratory at WHO, Meeting of the Strategic Advisory Group of Experts on Immunization, April 2013 conclusions and recommendations, World Health Organization Weekly Epidemiological Record, 88(20): , Yactayo S et al. Yellow fever in Africa and the Americas, 2014, World Health Organization Weekly Epidemiological Record, 90 (26): , WHO, The Yellow Fever Initiative: Towards the elimination of yellow fever outbreaks, World Health Organization, WHO, Global Strategy to eliminate Yellow Fever Epidemics, , Geneva, World Health Organization, December World Health Organization (2015). The International Health Regulations (2005). Second Edition, accessed on 17 April 2016 at: Angola, Benin, Burkina Faso, Cameroon, Central African Republic, Chad, Congo, Côte d Ivoire, Democratic Republic of the Congo, Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, Kenya, Liberia, Mali, Niger, Nigeria, Sao Tome and Principe, Senegal, Sierra Leone and Togo. All except Algeria, Botswana, Cabo Verde, Comoros, Lesotho, Madagascar, Malawi, Mauritius, Mozambique, Namibia, Seychelles, South Africa, Swaziland and Zimbabwe. Angola, Benin, Burkina Faso, Cameroon, Central African Republic, Côte d Ivoire, Democratic Republic of the Congo, Gabon, Ghana, Guinea, Liberia, Mali, Nigeria, Senegal, Sierra Leone and Togo.
5 Page 2 Institut Pasteur, Dakar (IPD). In addition, technical support for laboratory networks continues to be provided by WHO and the United States Centers for Disease Control and Prevention (CDC), thanks to financial support from Gavi, the Vaccine Alliance. 7. Following early success of the YF investment case, Gavi endorsed additional support for African countries at medium risk of YF outbreaks in December 2013 to complement PMVCs and routine immunization. Nevertheless, over 440 million people remain at risk of YF in the African Region. 8. To achieve effective YF control, vaccine demand must match supply. In this regard, the emergency stockpile of YF vaccines has increased from 2 million to 6 million doses annually and vaccine production has increased from 30 million doses in 2000 to over 83 million doses in Importantly, over 63 million people have been protected using the global YF emergency vaccine stockpile, as emergency reactive vaccination campaigns for over 65 YF outbreaks that occurred between 2001 and In 2016, Angola experienced the largest YF outbreak in recent history. This outbreak was protracted, with wide geographic spread from the initial epicentre in Luanda. The outbreak spread to 123 districts in 16 out of 18 provinces with 884 laboratory confirmed cases, including 121 deaths (13.7% case fatality ratio). 10 The Angola outbreak further spread to DRC with additional cases imported to Kenya and China, demonstrating that YF is a serious health security risk that requires new strategic actions. ISSUES AND CHALLENGES 10. Inadequate and overly rigid vaccination strategies. The limitation of routine vaccination to children under 11 months old and the unwillingness of health providers to open a 10 or 20 dose vial for one child remain major challenges. In addition, priority for vaccines supply is always given to outbreak response rather than outbreak prevention. As a result, childhood immunization coverage is too low to maintain sufficient herd immunity. Due to competing vaccine introduction priorities and limited political will, no new country has introduced the YF vaccine into national routine immunization programmes since Nine countries 11 in East and Central Africa do not have YF vaccination in routine immunization programmes. Moreover, no PMVCs have been conducted, resulting in YF outbreaks. 11. Limited vaccine supply and emergency stockpile. Between 2013 and 2015, fifteen countries among the 23 that introduced the YF vaccine into their routine immunization programmes reported YF vaccine stock-outs at national level. Consequently, vaccine coverage has stagnated. Prior to the epidemic in Angola and the Democratic Republic of the Congo, only 6 million doses were reserved annually as emergency stockpile to respond to any YF outbreaks. In 2016, the YF emergency stockpile was replenished twice and exceeded 18 million doses to enable the control of the YF outbreaks in Angola, DRC and Uganda. 12. Weak coordination and surveillance. Yellow fever vaccination requirements are clearly stated in the International Health Regulations (IHR 2005), but are not being fully implemented. 12 Past efforts to control YF have not been sufficiently aligned and have failed to bring partners WHO, The Yellow Fever Initiative: Towards the elimination of yellow fever outbreaks, World Health Organization, WHO, Yellow Fever Outbreak Situation Report, Angola, World Health Organization, December Burundi, Equatorial Guinea, Eritrea, Ethiopia, Rwanda, South Sudan, United Republic of Tanzania, Uganda and Zambia. WHO, Implementation of International Health Regulations (2005) in the WHO African Region, Luanda, World Health Organization, 2012 (AFR/RC62/12).
6 Page 3 together under a common vision and a single coordinated and effective mechanism. Crucial functions such as surveillance, laboratory capacity and case management have often lacked an integrated approach. Despite the existence of national laboratory networks using standardized methods and tools for early detection and confirmation of YF, inadequate laboratory capacity continues to be a challenge. 13. Environmental risk. Deforestation, climate change, incursions into forests and jungles for mining, construction and agriculture continue to maintain a high volume of contacts between humans, the animal reservoir and the vectors. All these factors contribute to the proliferation of and exposure of humans to infected mosquitoes, maintaining transmission and driving the change in YF epidemiology. Although YF outbreaks have been well documented in many countries in the past decade, the exact extent of the risk of re-emergence is uncertain due to inadequate risk assessments, hence the need for the EYE implementation framework. 14. Risk specific to urban outbreaks. Rapid and unplanned urbanization, high population growth, low population herd immunity, coupled with frequent population movements to and from affected areas, create conditions which increase transmissibility. Responding to outbreaks in large urban settings is challenging and costly due to their rapid amplification and risk of international spread, resulting in high negative public health, economic, social and political impact. THE REGIONAL IMPLEMENTATION FRAMEWORK Vision, goal, objectives, targets and milestones Vision 15. A Region free of YF epidemics. Goal 16. To eliminate YF epidemics in the African Region by Objectives 17. The objectives are: (a) To protect populations in all 35 countries at risk through preventive and routine vaccination. (b) To prevent international spread of YF through vaccination of travellers and robust screening and onsite vaccination for people not vaccinated at major points of entry. (c) To rapidly detect, confirm and contain outbreaks. Targets 18. By the end of 2026: (a) All high-risk countries will have completed national preventive mass vaccination campaigns. (b) At least 440 million people will have been vaccinated in the African Region.
7 Page 4 Milestones 19. The key milestones are: By the end of 2019: (a) All at-risk countries will have initiated the implementation of this framework. (b) Three regional reference laboratories will have fully functional confirmation capacity. (c) All high-risk countries will have introduced YF vaccination into routine immunization (see Annexes 1 and 2 for risk categorization and indicators, respectively). (d) Preventive mass campaigns will have been completed in Angola, Congo (Republic) and Ghana and will have been initiated in DRC, Nigeria and Uganda. By the end of 2022: (a) Six subregional reference laboratories will be fully functional for both serology and molecular diagnosis of YF. (b) Six of the 13 high-risk countries will have completed preventive mass vaccination campaigns and three new ones (Guinea-Bissau, Ethiopia and South Sudan) will have initiated mass preventive campaigns (see Annex 2 for sequencing). (c) All high-risk countries will have established diagnostic capacity to confirm YF. Guiding principles 20. The guiding principles that underpin the framework are: (a) Country ownership and leadership: Governments will own, coordinate and ensure that all interventions by partners are in line with relevant national guidelines. (b) Community participation: The engagement of communities, civil society and the private sector is critical for the success of this framework. (c) Gender and human rights: The implementation of this framework will ensure incorporation of gender equity and human rights perspectives. (d) Equity: All actions should ensure access for all to services, including vulnerable populations, migrant populations, under-served areas and states emerging from civil strife. (e) Partnerships: A broad range of stakeholders within and outside the health sector, with research and academic institutions, will be involved in all actions. (f) Intersectoral collaboration: It is critical to ensure intersectoral collaboration at local and regional levels between human health, animal health, the environment and wildlife sectors using the One Health approach. (g) Evidence-led and forward looking: All actions should take into account emerging trends, risks and health innovations. (h) Intercountry, regional, subregional and cross-border cooperation: This will ensure coordinated interventions within and among Member States. (i) Rapid information sharing: In line with IHR (2005), Member States, WHO and partners will ensure that there is transparency and rapid information sharing about YF risk assessments and timely notification of YF outbreaks.
8 Page 5 PRIORITY INTERVENTIONS AND ACTIONS 21. Undertaking risk assessment and catch-up campaigns. Member States should regularly undertake risk assessments, using WHO recommended methodology, 13 and should revise the YF classification, in line with the IHR (2005) requirements. Where many people are susceptible due to low routine vaccination coverage, targeted catch-up campaigns are recommended to reach under-vaccinated cohorts. These could, for example, target age-specific vaccination gaps or geographic areas where population immunity is low. 22. Applying the IHR (2005). The strict implementation of IHR (2005) for travellers to and from countries at risk of YF is paramount to prevent, detect and respond to potential epidemic threats. Port and border control authorities need to be actively engaged to identify gaps and ensure that the vaccination status of all travellers entering and leaving endemic areas is known and appropriate action immediately taken. All countries need to engage transportation agencies and border control authorities to strengthen screening for YF immunization status, with capacity for onsite vaccination of defaulters. 23. Vaccinating everyone in areas or countries at high risk of YF. In 13 Member States identified as at very high risk, no PMVCs have been conducted since the YF Initiative commenced. PMVCs targeting all age groups should be conducted in these Member States to rapidly raise population herd immunity. Member States that are yet to complete national PMVCs such as Ghana and Nigeria are also included in this category. 24. Improving routine immunization and vaccinating every child. The best way to maintain high herd immunity in high-risk countries is to ensure that all new cohorts are immunized in infancy. High coverage in successive cohorts will gradually ensure that the population immunity does not decrease after mass vaccination campaigns. All 13 Member States at high risk should introduce YF vaccination into the national routine vaccination schedule so as to achieve and sustain population coverage of over 80%. To achieve this target, YF vaccine stocks (see Annex 3) and ancillary supplies should be reliable, and political and financial commitment should be increased to ensure that children, displaced populations and refugees are vaccinated. Further, community engagement should be conducted at all levels. Importantly, synergies should be maximized with other programmes such as the prevention of measles. Finally, the knowledge and awareness of health-care workers about the importance of childhood YF vaccination should be heightened. Close monitoring of interventions is required to ensure good coverage (see Annex 4). 25. Protecting high-risk workers. People working in a wide range of extractive industries such as oil, mining, construction and forestry are at high risk of developing and spreading YF locally and internationally. These workers are particularly exposed to sylvatic transmission when they work or reside in forest or recently deforested areas. Member States are urged to establish political and technical steering committees consisting of relevant companies, industries and stakeholders from relevant sectors to develop strategies to protect local and international workers who are at risk. The private sector should be actively engaged to ensure that their staff and families are protected. 26. Building resilient urban centres and establishing readiness plans. Reducing the risk of epidemics in urban centres requires increased readiness. Member States are urged to formulate plans for timely and rapid vaccination during urban outbreaks as part of the overall urban readiness plans, conduct continuous risk assessment and formulate plans for transportation hubs. 13 WHO, Risk assessment on yellow fever virus circulation in endemic countries: Working document from an informal consultation of experts, A Protocol for risk assessment at the field level, Geneva, World Health Organization, 2014.
9 Page Sustaining vector surveillance and control programmes in cities. Aedes aegypti indices should be measured regularly in cities at risk or with potential for YF. Such monitoring should be integrated into urban emergency planning and should trigger activities based on the estimated level of risk. These measures should be part of a broader arbovirus surveillance and readiness plan in countries at risk of Dengue, Zika and Chikungunya viruses. Integrated vector management requires sustained efforts to maintain low mosquito density, particularly for the Aedes vectors which are well adapted to humans. Communities should be engaged in the management of the environment to reduce breeding sites. 28. Strengthening surveillance and diagnosis for early detection. In all Member States, the Integrated Disease Surveillance and Response strategy will be the foundation for YF surveillance. Community-based surveillance should be promoted for early warning. The adaptation and strengthening of case-based surveillance should focus on: (i) revision of national surveillance guidelines, based on WHO and partners guidance; (ii) training of health workers to improve diagnosis and collection of YF vaccination information; and (iii) establishment of a national database of YF epidemiological and laboratory confirmed cases. All Member States should enhance their national laboratory capacity with the availability of reagents in adequate quantities and should establish a specimen referral network. It will be essential to establish agreements with transportation companies and to have protocols of cooperation between Member States for the safe transportation and shipment of specimens. Strengthening external quality assurance and quality control (EQA/QC) for laboratories should be fully functional and monitored for molecular and serological diagnosis. Member States should work with WHO and partners to develop, test and validate new methods for diagnostic confirmation. 29. Regional and subregional networks. At the regional level, WHO and partners should establish a regional surveillance network bringing together all high-risk countries to facilitate standardization of case definitions and diagnostic procedures. Furthermore, the number of regional and subregional reference laboratories should, as a matter of urgency, be increased. WHO and partners should support these regional laboratories to ensure that they have molecular and serological capacity complying with international standards. 30. Ensuring emergency stockpile of YF vaccines. Emergency stockpiles ensure timely and equitable access to vaccines during emergencies. WHO and partners should work with the International Coordinating Group (ICG) on Vaccine Provision for YF to implement a new stockpile model to maintain a revolving emergency stock of 6 million doses at any time over a given year. The stockpile should be replenished after its use to respond to an outbreak as soon as released vaccines become available. 31. Fostering rapid outbreak response. An effective YF outbreak response requires rapid detection of cases, reactive vaccination, good case management and vector control, and community mobilization. Rapid investigation with emphasis on assessing the risk of spread (transportation hubs, population movements, points of entry and vector density) should be streamlined. Efforts should be made to provide essential information and mobilize communities through social mobilization and risk communication. Member States are urged to conduct preemptive vaccination campaigns during any ongoing YF outbreak in areas that are not affected but face heightened risk and vulnerability due to weak surveillance or where population immunity is low. Actions proposed 32. The Regional Committee is invited to examine and adopt the priority interventions and actions proposed in this Framework.
10 ANNEX 1: Priority interventions to eliminate YF epidemics in the African Region AFR/RC67/8 Page 7 Country Yellow Fever Vaccination Improve surveillance, Strengthen screening & Routine Mass campaign lab & response capacity vaccination at points of entry Algeria N N Y Y Angola Y Y Y Y Benin Y N Y Y Botswana N N Y Y Burkina Faso Y N Y Y Burundi N N Y Y Cameroon Y N Y Y Cabo Verde N N Y Y CAR Y N Y Y Chad Y Y Y Y Comoros N N Y Y Congo Y Y Y Y Côte d Ivoire Y N Y Y D R Congo Y Y Y Y Equatorial Y Y Guinea Y Y Eritrea Y N Y Y Ethiopia Y Y Y Y Gabon Y Y Y Y Gambia Y N Y Y Ghana Y Y Y Y Guinea Y N Y Y Guinea-Bissau Y Y Y Y Kenya Y N Y Y Lesotho N N Y Y Liberia Y N Y Y Madagascar N N Y Y Malawi N N Y Y Mali Y N Y Y Mauritania N N Y Y Mauritius N N Y Y Mozambique N N Y Y Namibia N N Y Y Niger Y Y Y Y Nigeria Y Y Y Y Rwanda N N Y Y Sao Tome and Y Y Principe N N Senegal Y N Y Y Seychelles N N Y Y Sierra Leone Y N Y Y South Africa N N Y Y South Sudan Y Y Y Y Swaziland N N Y Y Tanzania N N Y Y Togo Y N Y Y Uganda Y Y Y Y Zambia N N Y Y Zimbabwe N N Y Y Yes = 27 Yes = 13 All the 47 countries All the 47 countries Y = yes; N = no. All countries will need to continue to carry out regular risk assessments and conduct catch-up campaigns when required.
11 Page 8 Annex 2: Proposed sequencing of preventive mass vaccination campaigns over time, Africa (Number of doses (1000s) 14 Country TOTAL 1. Angola Ghana Nigeria Democratic Republic of the Congo 5. Congo Uganda Guinea-Bissau Ethiopia South Sudan Equatorial Chad Niger Gabon TOTAL WHO, Global Strategy to eliminate Yellow Fever Epidemics, , Geneva, World Health Organization, December 2016.
12 Page 9 ANNEX 3: Global YF vaccine supply outlook The global supply of YF vaccines is expected to increase to between 105 and 132 million doses in 2017, to between 116 and 159 million doses in 2021, and to between 162 and 183 million doses in The increased capacity expected during should be achieved by prioritizing and optimizing YF vaccine production and contracting manufacturer operations for filling and freeze-drying. New production capacity is mainly expected after 2021, when new facilities of two manufacturers will start production. Estimated global YF vaccine supply (high to low risk-adjusted estimates),
13 Page 10 ANNEX 4: Key Regional indicators The following indicators will be measured on a regular basis to reflect implementation and impact of the EYE strategy. Preventive mass vaccination campaigns (a) Number of countries which mounted preventive mass vaccination campaigns. (b) Number of persons vaccinated. (c) District-level coverage. (d) Wastage rate. (e) Rate of adverse events following immunization (AEFI) and severe adverse effects. Routine immunization (a) Number of persons vaccinated. (b) Proportion of district with coverage level < 80%. (c) Difference between YF, DTP3 and measles coverage; (WUENIC). (d) Number of vaccine stock-outs. Laboratory capacity Number of Regional and national reference laboratories with appropriate diagnostic capacity for YF. Application of International Health Regulations (2005) (a) Immunization status checked upon entry in country. (b) Immunization status checked upon departure from country. Impact Number of urban outbreaks.
THE SITUATION OF YELLOW FEVER IN THE AFRICAN REGION: THE PLAN TO END YF EPIDEMICS IN 2026
THE SITUATION OF YELLOW FEVER IN THE AFRICAN REGION: THE PLAN TO END YF EPIDEMICS IN 2026 Dr Zabulon Yoti WHO AFRO Technical Coordinator for Health Emergencies 1 About 100 acute public health events annually
More informationPROGRESS REPORT ON THE ROAD MAP FOR ACCELERATING THE ATTAINMENT OF THE MILLENNIUM DEVELOPMENT GOALS RELATED TO MATERNAL AND NEWBORN HEALTH IN AFRICA
5 July 2011 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixty-first session Yamoussoukro, Côte d Ivoire, 29 August 2 September 2011 Provisional agenda item 17.1 PROGRESS REPORT ON THE ROAD MAP FOR
More informationMEASLES ELIMINATION BY 2020: A STRATEGY FOR THE AFRICAN REGION. Report of the Secretariat. Executive Summary
16 June 2011 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixty-first session Yamoussoukro, Côte d Ivoire, 29 August 2 September 2011 Provisional agenda item 13 MEASLES ELIMINATION BY 2020: A STRATEGY
More informationIMMUNIZATION & VACCINE PREVENTABLE DISEASES
IMMUNIZATION & VACCINE PREVENTABLE DISEASES MONTHLY IMMUNIZATION UPDATE IN THE AFRICAN REGION July-August 2015 (Vol 3, issue N 6 ) Special issue on WHO/UNICEF Estimates of National Immunization Coverage
More informationCONTENTS. Paragraphs I. BACKGROUND II. PROGRESS REPORT ON THE AFRICAN REGIONAL IMMUNIZATION STRATEGIC PLAN
23 September 2013 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixty-third session Brazzaville, Republic of Congo, 2 6 September, 2013 Agenda item 14 IMMUNIZATION IN THE AFRICAN REGION: PROGRESS REPORT
More informationPOLIOMYELITIS ERADICATION: PROGRESS REPORT. Information Document CONTENTS BACKGROUND PROGRESS MADE NEXT STEPS... 12
5 August 9 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-ninth session Kigali, Republic of Rwanda, August 4 September 9 POLIOMYELITIS ERADICATION: PROGRESS REPORT Information Document CONTENTS
More informationPROGRESS REPORT ON CHILD SURVIVAL: A STRATEGY FOR THE AFRICAN REGION. Information Document CONTENTS
29 June 2009 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-ninth session Kigali, Republic of Rwanda, 31 August 4 September 2009 Provisional agenda item 9.2 PROGRESS REPORT ON CHILD SURVIVAL: A
More informationIMMUNIZATION VACCINES & EMERGENCIES
No report No data No data IMMUNIZATION VACCINES & EMERGENCIES ROUTINE IMMUNIZATION PERFORMANCE IN THE AFRICAN REGION October 2013 issue Number of children vaccinated with the 3 rd dose of DTPcontaining
More informationWhat is this document and who is it for?
Measles and Rubella Initiative s Standard Operating Procedures for Accessing Support for Measles and Rubella Supplementary Immunization Activities During 2016 In the context of measles and rubella elimination
More information1) SO1: We would like to suggest that the indicator used to measure vaccine hesitancy be DTP 1 to measles first dose dropout.
To SAGE Secretariat, WHO Dear Professor Helen Rees, Dear Dr. Jean Marie Okwo-Bele, On behalf of the Civil Society Constituency of the GAVI Alliance, we would like to thank SAGE and its members for the
More informationANNEX Page. AFR/RC61/11 4 July 2011 ORIGINAL: ENGLISH REGIONAL COMMITTEE FOR AFRICA
4 July 2011 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixty-first session Yamoussoukro, Côte d Ivoire, 29 August 2 September 2011 Provisional agenda item 16 PROGRESS REPORT ON POLIOMYELITIS ERADICATION
More informationPOLIO ERADICATION IN THE AFRICAN REGION: PROGRESS REPORT. Information document EXECUTIVE SUMMARY
7 July 2006 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-sixth session Addis Ababa, Ethiopia, 28 August 1 September 2006 Provisional agenda item 10.1 POLIO ERADICATION IN THE AFRICAN REGION: PROGRESS
More informationOuagadougou Declaration
Ouagadougou Declaration on Primary Health Care and Health Systems in Africa: Achieving Better Health for Africa in the New Millennium A declaration by the Members States of the WHO African Region 30 April
More informationIMMUNIZATION VACCINE DEVELOPMENT
IMMUNIZATION VACCINE DEVELOPMENT MONTHLY IMMUNIZATION UPDATE IN THE AFRICAN REGION July-August 2016 (Vol 4, issue N 5) Special issue on 2015 WHO/UNICEF Estimates of National Immunization Coverage (WUENIC)
More informationUpdate on Meningococcal A Vaccine Development and Introduction
Update on Meningococcal A Vaccine Development and Introduction WHO Product Development for Vaccines Advisory Committee Meeting (PD-VAC) @ Geneva, 7-9 September 2015 Dr Marie-Pierre Preziosi, WHO Initiative
More informationMalaria Funding. Richard W. Steketee MACEPA, PATH. April World Malaria Day 2010, Seattle WA
Malaria Funding Richard W. Steketee MACEPA, PATH April World Malaria Day 2010, Seattle WA Malaria Funding Is there a plan? Is there money? Where does the money come from? Is the money moving efficiently?
More informationAIDS in Africa. An Update. Basil Reekie
AIDS in Africa An Update Basil Reekie Contents General Statistics The trend of HIV in Africa Ugandan experience UNAIDS 2006 Latest African Statistics by Country HIV Intervention Light at the end of the
More informationYellow fever Vaccine investment strategy
Yellow fever Vaccine investment strategy Background document #5 November 2013 Executive summary Since 2001, GAVI has spent ~$250M on yellow fever control $102M on routine vaccination in 17 countries ~$160M
More informationGlobal reductions in measles mortality and the risk of measles resurgence
Global reductions in measles mortality 2000 2008 and the risk of measles resurgence Measles is one of the most contagious human diseases. In 1980 before the use of measles vaccine was widespread, there
More informationASLM Anti-microbial Resistance in Africa and Global Health Security. 9TH INTEREST WORKSHOP May 2015 Harare
ASLM Anti-microbial Resistance in Africa and Global Health Security 9TH INTEREST WORKSHOP 2015 8 May 2015 Harare Recent Jim O Neil Report commissioned by the UK government predicts dire consequences of
More informationCANCER OF THE CERVIX IN THE AFRICAN REGION: CURRENT SITUATION AND WAY FORWARD
23 June 2010 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: FRENCH Sixtieth session Malabo, Equatorial Guinea, 30 August 3 September 2010 Provisional agenda item 7.4 CANCER OF THE CERVIX IN THE AFRICAN REGION:
More informationHIBA ABDALRAHIM Capsca Focal Point Public Health Authority
HIBA ABDALRAHIM Capsca Focal Point Public Health Authority Introduction Definition Symptom Transmission Global situation Local situation Control Content Introduction Yellow fever (YF) is a mosquito-borne
More informationYellow fever laboratory capacity on-site assessments in Africa: preliminary findings
Yellow fever laboratory capacity on-site assessments in Africa: preliminary findings Maurice Demanou*, Barbara W. Johnson, Gamou Fall, Jean-Luc Betoulle, Chantal Reusken, Marion Koopmans, Lee Hampton,
More informationTFI Proceedings, Recommendations and implications for 2005
January 2005 N 053 TFI 2004 - Proceedings, Recommendations and implications for 2005 The 12th meeting of the Task Force on Immunization (TFI) in Africa and the 11th meeting of the Africa Regional Inter-
More informationAnnex 2 A. Regional profile: West Africa
Annex 2 A. Regional profile: West Africa 355 million people at risk for malaria in 215 297 million at high risk A. Parasite prevalence, 215 Funding for malaria increased from US$ 233 million to US$ 262
More informationGABON. Neglected tropical disease treatment report profile for mass treatment of NTDs
GABON Neglected tropical disease treatment report 2017 1 2017 profile for mass treatment of NTDs NEGLECTED TROPICAL DISEASES Neglected tropical diseases (NTDs) are a group of preventable and treatable
More informationPROGRESS ON HEALTH-RELATED MILLENNIUM DEVELOPMENT GOALS AND THE POST 2015 HEALTH DEVELOPMENT AGENDA. Report of the Secretariat CONTENTS ANNEXES
26 November 2015 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixty-fifth session N Djamena, Republic of Chad, 23 27 November 2015 Agenda item 8 PROGRESS ON HEALTH-RELATED MILLENNIUM DEVELOPMENT GOALS
More informationUNAIDS 2013 AIDS by the numbers
UNAIDS 2013 AIDS by the numbers 33 % decrease in new HIV infections since 2001 29 % decrease in AIDS-related deaths (adults and children) since 2005 52 % decrease in new HIV infections in children since
More informationExpert Group Meeting on the Regional Report for the African Gender and Development Index
Expert Group Meeting on the Regional Report for the African Gender and Development Index 9-10 October 2017 United Nations Conference Centre, Addis Ababa, Ethiopia Aide Memoire July 2017 I. Background and
More informationZika Outbreak: a PHEIC & Zika virus preparedness and response ac:vi:es in the African Region. Dr Zabulon Yo, & Dr Anthony Stewart
Zika Outbreak: a PHEIC & Zika virus preparedness and response ac:vi:es in the African Region Dr Zabulon Yo, & Dr Anthony Stewart Presenta:on Outline Background informa:on on Zika Global situa:on and Zika
More informationProgress has been made with respect to health conditions.
health Strong performers in reducing child mortality 199-2 Niger Guinea-Bissau Guinea Ethiopia Benin 2 199 Strong performers in reducing maternal mortality 199-2 Djibouti Madagascar Eritrea Comoros Somalia
More informationPROGRESS REPORT ON DECADE OF TRADITIONAL MEDICINE IN THE AFRICAN REGION. Progress Report. CONTENTS Paragraphs BACKGROUND PROGRESS MADE...
5 July 2011 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixty-first session Yamoussoukro, Côte d Ivoire, 29 August 2 September 2011 Provisional agenda item 17.2 PROGRESS REPORT ON DECADE OF TRADITIONAL
More informationPneumococcal Conjugate Vaccine: Current Supply & Demand Outlook. UNICEF Supply Division
Pneumococcal Conjugate Vaccine: Current Supply & Demand Outlook UNICEF Supply Division Update: October 2013 0 Pneumococcal Conjugate Vaccine (PCV) Supply & Demand Outlook October 2013 Update Key updates
More informationIMMUNIZATION VACCINE DEVELOPMENT
IMMUNIZATION VACCINE DEVELOPMENT IMMUNIZATION AND POLIO UPDATE IN THE AFRICAN REGION July August 2017 (Vol 5 issue N 4) Special issue featuring WHO/UNICEF Estimates of National Immunization Coverage (WUENIC
More informationInfluenza Surveillance In the WHO African Region
Vol. 2 N 52, Updated on 2 January 207 Contents Highlights ackground Methodology Review of 206 influenza virus circulation Seasonal patterns of influenza transmission Way forward Conclusion Editor Dr Ibramima
More informationScaling Up Nutrition Action for Africa
Scaling Up Nutrition Action for Africa Where are we and what challenges are need to be addressed to accelerate malnutrition? Lawrence Haddad Global Alliance for Improved Nutrition Why should African political
More informationYellow fever. Key facts
From: http://www.who.int/en/news-room/fact-sheets/detail/yellow-fever WHO/E. Soteras Jalil Yellow fever 14 March 2018 Key facts Yellow fever is an acute viral haemorrhagic disease transmitted by infected
More informationOverview of WHO/UNICEF Immunization Coverage Estimates
Overview of WHO/UNICEF Immunization Coverage Estimates Marta Gacic-Dobo, Anthony Burton, David Durrheim Meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) 8-10 November 2011 CCV/CICG,
More informationPerformance of National Measles Case-Based Surveillance Systems in The WHO African Region
Research Article Open Access Performance of National Measles Case-Based Surveillance Systems in The WHO African Region. 2012 2016 Balcha Masresha 1 *, Reggis Katsande 1, Richard Luce 2, Amadou Fall 3,
More informationHealth systems and HIV: advocacy. Interagency Coalition on AIDS and Development
Health systems and HIV: Priorities for civil society advocacy Michelle Munro Interagency Coalition on AIDS and Development 1 Overview GTAG, civil society and health systems advocacy Health systems and
More informationIMMUNIZATION VACCINE DEVELOPMENT
IMMUNIZATION VACCINE DEVELOPMENT MONTHLY IMMUNIZATION AND POLIO UPDATE IN THE AFRICAN REGION January February 2017 (Vol 5 issue N 1) District data completeness and coverage of DTP3 containing vaccine per
More informationUpdate from GAVI Aurelia Nguyen
Update from GAVI Aurelia Nguyen (Copenhagen, Denmark, 27 June 2012) GAVI vaccine support Currently supported vaccines: pentavalent, pneumococcal, rotavirus, meningitis A, human papillomavirus (HPV), rubella,
More informationStatus Report on WSS MDG Roadmaps and Country Status Overviews WSP Africa
Status Report on WSS MDG Roadmaps and Country Status Overviews WSP Africa Ede Ijjasz Global Manager Water and Sanitation Program World Water Forum, Mexico, March 18, 2006 Outline 1. The Water Supply and
More informationAFRICA. The continent of All challenges
AFRICA The continent of All challenges Part of Resources and burden of the disease in Africa Africa=25% Rest of the World=75% Africa=0.6% Rest of the World=99.4% 0% 20% 40% 60% 80% 100% 57 Critical shortage
More informationENHANCING THE ROLE OF TRADITIONAL MEDICINE IN HEALTH SYSTEMS: A STRATEGY FOR THE AFRICAN REGION. Report of the Secretariat EXECUTIVE SUMMARY
3 September 2013 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixty-third session Brazzaville, Republic of Congo, 2 6 September 2013 Agenda item 10 ENHANCING THE ROLE OF TRADITIONAL MEDICINE IN HEALTH
More informationTHE WHO FRAMEWORK CONVENTION ON TOBACCO CONTROL: 10 YEARS OF IMPLEMENTATION IN THE AFRICAN REGION
THE WHO FRAMEWORK CONVENTION ON TOBACCO CONTROL: 10 YEARS OF IMPLEMENTATION IN THE AFRICAN REGION AFRO Library Cataloguing-in-Publication Data The WHO Framework Convention on Tobacco Control: 10 years
More informationFighting Harder and Smarter Against Malaria. Dr.Bernard Nahlen Deputy US Global Malaria Coordinator University of Georgia, February 23, 2010
Fighting Harder and Smarter Against Malaria Dr.Bernard Nahlen Deputy US Global Malaria Coordinator University of Georgia, February 23, 2010 Outline Burden of malaria Global support for rolling back malaria
More informationTURNING POINT FOR AFRICA AN HISTORIC OPPORTUNITY TO END AIDS AS A PUBLIC HEALTH THREAT BY 2030 AND LAUNCH A NEW ERA OF SUSTAINABILITY
TURNING POINT FOR AFRICA AN HISTORIC OPPORTUNITY TO END AIDS AS A PUBLIC HEALTH THREAT BY 2030 AND LAUNCH A NEW ERA OF SUSTAINABILITY UNAIDS 2018 II KEY MESSAGES 1 Ending the AIDS epidemic in Africa is
More informationASLM Building laboratory capacity in Africa in a sustainable way
ASLM Building laboratory capacity in Africa in a sustainable way Tsehaynesh Messele, PhD ASLM, Chief Executive Officer Annual AMDS meeting September 29-30, 2014 Geneva Laboratory capacity gaps in Africa
More informationGAVI S CONTINUED ROLE IN YELLOW FEVER CONTROL
GAVI S CONTINUED ROLE IN YELLOW FEVER CONTROL BOARD MEETING Michael F Thomas, Abidjan, Côte d Ivoire Reach every child www.gavi.org EVOLVING CONTEXT: THREATS AND OPPORTUNITIES Yellow fever is a global
More informationAgeing and mental health resources for older persons in the African region of the World Health Organization
Ageing and mental health resources for older persons in the African region of the World Health Organization Carlos Augusto de Mendonça Lima Instituto de Psiquiatria CDA, Universidade Federal do Rio de
More informationHPV Vaccine Lessons Learned & New Ways Forward
HPV Vaccine Lessons Learned & New Ways Forward The Gavi Alliance June 2016, Geneva www.gavi.org Overview 1 Background 2 Lessons learned 3 New Way Forward 2 1 Background 3 HPV Background HPV is responsible
More informationYellow Fever Vaccine: Current Outlook. UNICEF Supply Division
Yellow Fever Vaccine: Current Outlook UNICEF Supply Division March 2015 0 Yellow Fever Vaccine - Current Outlook March 2015 This update provides revised information on the continued constrained 2014-2017
More informationReport to the Board 7-8 December 2016
Report to the Board 7-8 December 2016 SUBJECT: GAVI S CONTINUED ROLE IN YELLOW FEVER CONTROL Agenda item: 14 Category: Authored by: For Decision Patience Musanhu, Stephen Sosler and Michael F Thomas Executive
More informationPrioritizing Emergency Polio Eradication Activities
Prioritizing Emergency Polio Eradication Activities Managing the Financing Gap the other half of the Emergency Hamid Jafari GPEI Financing 2012-13: Budget = $2.23 b - Confirmed contributions = $1.14 b
More informationGlobal Vaccine Action Plan
Global Vaccine Action Plan Regional reports on progress towards GVAP RVAP goals Annex to the GVAP Secretariat Annual Report 2017 World Health Organization 2017 Some rights reserved. This work is available
More informationUpdate from the GAVI Alliance Seth Berkley, MD Chief Executive Officer
Update from the GAVI Alliance Seth Berkley, MD Chief Executive Officer SAGE meeting Geneva, 8-10 November 2011 Topics to cover Update on new vaccine introduction Introductions New approvals Co-financing
More informationTT Procured by UNICEF
TT TT Procured by UNICEF 2001-08 250,000,000 200,000,000 150,000,000 100,000,000 50,000,000 0 2001 2002 2003 2004 2005 2006 2007 2008 Routine SIA TT historical demand and forecast overview Upcoming Tender
More informationCOLD CHAIN EQUIPMENT OPTIMISATION PLATFORM (CCEOP)
COLD CHAIN EQUIPMENT OPTIMISATION PLATFORM (CCEOP) Sushila Maharjan Senior Manager, Innovative Finance International Conference on Sustainable Cooling World Bank Washington DC - 29 November 2018 Reach
More informationYELLOW FEVER UPDATE. DPGH Meeting Dr. Grace Saguti NPO/DPC 13 July 2016
YELLOW FEVER UPDATE DPGH Meeting Dr. Grace Saguti NPO/DPC 13 July 2016 Outline Introduction Yellow fever situation report & Risk Assessment: Angola WHO Recommendations Vaccination TZA status & Action Undertaken
More informationProgress Report: Universal Access Target Setting in East and Southern Africa
Progress Report: Universal Access Target Setting in East and Report prepared by: Team for East & 15 September 2006 For all inquiries please contact Mark Stirling, Regional Director for Eastern and, at
More informationAboubacar Kampo Chief of Health UNICEF Nigeria
Aboubacar Kampo Chief of Health UNICEF Nigeria Many thanks to UNICEF colleagues in Supply Division-Copenhagen and NY for contributing to this presentation Thirty-five countries are responsible for 98%
More informationSITUATION REPORT YELLOW FEVER 20 MAY 2016 SUMMARY
ZIKA VIRUS SITUATION REPORT YELLOW FEVER 20 MAY 2016 SUMMARY A yellow fever outbreak was detected in Angola late in December 2015 and confirmed by the Institut Pasteur Dakar (IP-D) on 20 January 2016.
More information( A JICA-IRRI-PhilRice Initiative) Presented by Noel Magor, Head Unit Impact Acceleration and Training Center, IRRI
( A JICA-IRRI-PhilRice Initiative) Presented by Noel Magor, Head Unit Impact Acceleration and Training Center, IRRI Long partnership between; IRRI & PhilRice IRRI & JICA PhilRice & JICA The Season Long
More informationFollow-up to the high-level meetings of the United Nations General Assembly on health-related issues
EXECUTIVE BOARD EB44/ 44th session December 08 Provisional agenda item 5.8 Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues Ending tuberculosis Report
More informationUpdate on PMTCT. African Health Profession Regulatory Collaborative for Nurses and Midwives. Johannesburg, Republic of South Africa, June 18-22, 2012
PMTCT Update Update on PMTCT Margarett Davis, MD, MPH Chief, Maternal and Child Health Branch Division of Global HIV/AIDS Centers for Disease Control and Prevention (CDC) African Health Profession Regulatory
More informationEXPLANATION OF INDICATORS CHOSEN FOR THE 2017 ANNUAL SUN MOVEMENT PROGRESS REPORT
UNICEF / Zar Mon Annexes EXPLANATION OF INDICATORS CHOSEN FOR THE 2017 ANNUAL SUN MOVEMENT PROGRESS REPORT This report includes nine nutrition statistics, as per the 2017 Global Nutrition Report. These
More informationCopenhagen, Denmark, September August Malaria
Regional Committee for Europe 64th session EUR/RC64/Inf.Doc./5 Copenhagen, Denmark, 15 18 September 2014 21 August 2014 140602 Provisional agenda item 3 ORIGINAL: ENGLISH Malaria Following the support
More informationGlobal Malaria Initiative
Global Malaria Initiative Appeal No. MAA00031 21/04/2009 This report covers the period 01/01/2008 to 31/12/2008. Volunteers from the Madagascar Red Cross participate in malaria behaviour change communication
More informationIMMUNIZATION VACCINE DEVELOPMENT
IMMUNIZATION VACCINE DEVELOPMENT MONTHLY IMMUNIZATION UPDATE IN THE AFRICAN REGION November December 2016 (Vol 4, issue N 7) District data completeness and coverage of DTP3 containing vaccine per country
More information! Multisectoral Information, Data, Research & Evidence - for Health, Population, Human & Social Development!
Pan African Campaign To End Forced Marriage of Under Age Children Advancing Multi-sectoral Policy & Investment for Girls, Women, & Children s Health 2015 Africa Scorecard On Maternal Health & Maternal
More informationAddressing climate change driven health challenges in Africa
Addressing climate change driven health challenges in Africa Ednah N Ototo, Parasitologist, Climate Change and Health Kenyatta University, Kenya Kenya Medical Research Institute Outline The impact of climate
More informationExcellence and Originality from Necessity: Palliative Care in Africa. Dr Emmanuel Luyirika Executive Director, African Palliative Care Association
Excellence and Originality from Necessity: Palliative Care in Africa Dr Emmanuel Luyirika Executive Director, African Palliative Care Association Summary of the presentation 1. Introduction 2. Background
More informationGOAL 2: ACHIEVE RUBELLA AND CRS ELIMINATION. (indicator G2.2) Highlights
GOAL 2: ACHIEVE RUBELLA AND CRS ELIMINATION (indicator G2.2) Highlights As of December 2014, 140 Member States had introduced rubella vaccines; coverage, however, varies from 12% to 94% depending on region.
More informationRotavirus Vaccine: Supply & Demand Update. UNICEF Supply Division
Rotavirus Vaccine: & Demand Update UNICEF Division July 0 Rotavirus Vaccine (RV): & Demand Update July This update provides new information on countries and their scheduled RV introductions, forecasted
More informationMedicines Regulation, Regulatory Harmonization, Global Initiatives. Tonya Villafana, PhD, MPH Senior Health Specialist, World Bank
Medicines Regulation, Regulatory Harmonization, Global Initiatives Tonya Villafana, PhD, MPH Senior Health Specialist, World Bank September, 13, 2012 Presentation Outline The importance of regulation Attributes
More informationAfrican Gender and Development Index
African Gender and Development Index EXPERTS MEETING ON METHODOLOGIES FOR REGIONAL INTEGRATION INDEX 26 SEPTEMBER 2018 ADDIS ABABA, ETHIOPIA Outline 1. The African Gender and Development Index 2. Gender
More informationPresentation title at-a-glance info (in slide master) Introduction to the Gavi CSO Platforms Project
Introduction to the Gavi CSO Platforms Project Raquel Fernandes Coordinator of the Oversight Advisory Group May 2018 Gavi CSO Constituency for Immunisation and Stronger Health Systems ~ 4000 Constituency
More informationGender, Poverty, and Health in Sub-Saharan Africa: A Framework for Analysis
Gender, Poverty, and Health in Sub-Saharan Africa: A Framework for Analysis Pathways to Improved Health Outcomes Health outcomes Households/ Communities Household behaviors & risk factors Community factors
More informationMeasles Supplementary Immunization Activities and GAVI Funds as Catalysts for Improving Injection Safety in Africa
SUPPLEMENT ARTICLE Measles Supplementary Immunization Activities and GAVI Funds as Catalysts for Improving Injection Safety in Africa Edward J. Hoekstra, 1 Maya M. V. X. van den Ent, 1 Halima Dao, 1 Hala
More informationImpact of Pathology Implementation Strategies in Sub Saharan Africa
Impact of Pathology Implementation Strategies in Sub Saharan Africa June 2015 ascp.org PATHOLOGY IN AFRICA Large abdominal wall mass What do you do?? Large lesion non-diagnostic? Have to do additional
More informationREGIONAL FRAMEWORK FOR THE IMPLEMENTATION OF THE GLOBAL STRATEGY FOR CHOLERA PREVENTION AND CONTROL, Report of the Secretariat
12 June 2018 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixty-eighth session Dakar, Republic of Senegal, 27 31 August 2018 Provisional agenda item 10 REGIONAL FRAMEWORK FOR THE IMPLEMENTATION OF THE
More informationThe Subcommittee met on Monday, 22 August 2005 and elected Dr Mantombazana Tshabalala Msimang, Minister of Health, South Africa, as its Chairman.
PROCEDURAL DECISIONS Decision 1: Composition of the Subcommittee on Nominations The Regional Committee appointed a Subcommittee on Nominations composed of the representatives of the following Member States:
More informationMDGs to Agenda 2063/SDGs
MDGs to Agenda 2063/SDGs Towards an integrated and coherent approach to sustainable development in Africa Infographics booklet MDG 1 ERADICATE EXTREME HUNGER AND POVERTY PROGRESS TOWARDS REDUCING POVERTY
More informationWHO Consultation on universal access to core malaria interventions in high burden countries: main conclusions and recommendations
WHO Consultation on universal access to core malaria interventions in high burden countries: main conclusions and recommendations 12-15 February 2018 Salle XI, ILO Building, Geneva, Switzerland Country
More informationComparative Analyses of Adolescent Nutrition Indicators
Comparative Analyses of Adolescent Nutrition Indicators Rukundo K. Benedict, PhD The DHS Program Stakeholders Consultation on Adolescent Girls Nutrition: Evidence, Guidance, and Gaps October 30 31, 2017
More informationThe Promise of Introducing Rubella Containing Vaccines on the Impact of Rubella and Measles Control
The Promise of Introducing Rubella Containing Vaccines on the Impact of Rubella and Measles Control GAVI Partners Forum 4 6 December 2012, Dar es Salaam, Tanzania Maya van den Ent, MPH, UNICEF Peter Strebel,
More informationEliminate Yellow Fever Epidemics (EYE)
A GLOBAL STRATEGY TO Eliminate Yellow Fever Epidemics (EYE) 2017 2026 Version 1 AUGUST 2017 A GLOBAL STRATEGY TO Eliminate Yellow Fever Epidemics (EYE) 2017 2026 Version 1 AUGUST 2017 Contents Foreword
More informationSpecific issues related to FMD surveillance in the eastern Africa sub-region. Gideon Brückner
Specific issues related to FMD surveillance in the eastern Africa sub-region Gideon Brückner 1 Why do we do surveillance for FMD? Demonstrating freedom from FMD, FMDV infection and/or FMDV transmission
More informationHealth situation analysis in the African Region. Basic indicators 2006
Health situation analysis in the African Region Basic indicators 2006 Health situation analysis in the African Region Basic indicators 2006 World Health Organization. Regional Office for Africa, 2006
More informationChildren in Africa. Key statistics on child survival, protection and development
Children in Key statistics on child survival, protection and development Key Statistics In, mortality rates among children under five decreased by 48 per cent between 199 and 13, but still half of the
More informationSITUATION REPORT YELLOW FEVER 26 MAY 2016 SUMMARY
ZIKA VIRUS SITUATION REPORT YELLOW FEVER 26 MAY 2016 SUMMARY A yellow fever outbreak was detected in Luanda, Angola late in December 2015. The first cases were confirmed by the National Institute for Communicable
More informationFP2020 Expert Advisory Community Webinar
FP2020 Expert Advisory Community Webinar Oct. 24, 2017 www.familyplanning2020.org #FP2020Progress @FP2020Global Facebook.com/familyplanning2020 AGENDA Welcome Key Updates: 2017 Family Planning Summit to
More informationEBOLA SITUATION REPORT
EBOLA SITUATION REPORT 11 FEBRUARY 2015 CASES/ DEATHS (data up to 8 February 2015) Guinea Liberia Sierra Leone Mali Nigeria Senegal Spain United Kingdom United States of America Total 8 6 20 8 1 0 1 0
More informationEBOLA SITUATION REPORT
4 MARCH 205 CORRIGENDUM CASES/ DEATHS (data up to March 205) Guinea Liberia Sierra Leone Mali Nigeria Senegal Spain United Kingdom United States of America Total 8 6 20 8 0 0 0 4 329 229 47 3546 9249 9807
More informationFunding for AIDS: The World Bank s Role. Yolanda Tayler, WB Bi-regional Workshop for the Procurement of ARVs Phnom Penh, Cambodia
Funding for AIDS: The World Bank s Role Yolanda Tayler, WB Bi-regional Workshop for the Procurement of ARVs Phnom Penh, Cambodia Outline New resources needs estimates Bridging the gap Global overview of
More informationBlood safety in Africa: Progress made during the last decade and major challenges for the Future
Blood safety in Africa: Progress made during the last decade and major challenges for the Future By J.B.Tapko Regional Advisor for Blood Safety WHO Regional Office for Africa Outline Introduction: WHO
More informationPlan of Presentation
CONTINENTAL CONFERENCE ON MATERNAL, INFANT AND CHILD HEALTH IN AFRICA Plan of Presentation Regional Frameworks on SRH Maputo Plan of Action Five-Year Review of MPoA What is CARMMA? Why CARMMA? What is
More informationOutbreaks and Emergencies Bulletin
Vol. 6 Issue 4, 30 June 2016 Content Introduction Overview of Public Health Events in the WHO African Region Yellow Fever outbreaks Cholera outbreaks Zika virus disease outbreak Other ongoing outbreaks
More informationNO MORE MISSED MDG4 OPPORTUNITIES: OPTIMIZING EXISTING HEALTH PLATFORMS FOR CHILD SURVIVAL. Measles & Rubella Campaigns
NO MORE MISSED MDG4 OPPORTUNITIES: OPTIMIZING EXISTING HEALTH PLATFORMS FOR CHILD SURVIVAL Measles & Rubella Campaigns With fewer than 600 days remaining to the Millennium Development Goal (MDG) deadline,
More information